HUT64082A - Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient - Google Patents

Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient

Info

Publication number
HUT64082A
HUT64082A HU9300901A HU9300901A HUT64082A HU T64082 A HUT64082 A HU T64082A HU 9300901 A HU9300901 A HU 9300901A HU 9300901 A HU9300901 A HU 9300901A HU T64082 A HUT64082 A HU T64082A
Authority
HU
Hungary
Prior art keywords
active ingredient
same
pharmaceutical compositions
steroid derivatives
producing steroid
Prior art date
Application number
HU9300901A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9300901D0 (en
Inventor
Don B Mclure
Jefferson Ray Mccowan
Joseph Matthew Pawlak
Ashraff Ali Rampersaud
Robert John Schmidt
Teri Ann Schreyer
Robert Allen Archer
Lisa Selsam Beavers
Robert Alan Gadski
Ho-Shen Lin
Melvin Joseph Yu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HU9300901D0 publication Critical patent/HU9300901D0/hu
Publication of HUT64082A publication Critical patent/HUT64082A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9300901A 1992-03-27 1993-03-26 Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient HUT64082A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85890892A 1992-03-27 1992-03-27
US1898593A 1993-03-03 1993-03-03

Publications (2)

Publication Number Publication Date
HU9300901D0 HU9300901D0 (en) 1993-06-28
HUT64082A true HUT64082A (en) 1993-11-29

Family

ID=26691704

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9300901A HUT64082A (en) 1992-03-27 1993-03-26 Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient

Country Status (12)

Country Link
EP (1) EP0562849A2 (enExample)
JP (1) JPH0656670A (enExample)
CN (1) CN1081682A (enExample)
AU (1) AU3551493A (enExample)
BR (1) BR9301342A (enExample)
CA (1) CA2092766A1 (enExample)
CZ (1) CZ50593A3 (enExample)
FI (1) FI931373A7 (enExample)
HU (1) HUT64082A (enExample)
IL (1) IL105050A0 (enExample)
MX (1) MX9301653A (enExample)
NO (1) NO931117L (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724174B1 (fr) 1994-09-06 1997-01-17 Roussel Uclaf Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires
US6444659B1 (en) * 1996-11-28 2002-09-03 Cognis Deutschland Gmbh Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic agents
CN1063449C (zh) * 1996-12-27 2001-03-21 中国科学院广州化学研究所 一种胆甾醇化合物及其提取方法
JP3873097B2 (ja) * 1997-11-06 2007-01-24 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
US6531462B2 (en) 1997-11-06 2003-03-11 Riken Medicament for treating obesity and improving lipid metabolism
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
GB9804861D0 (en) 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
US6579862B1 (en) 1999-01-12 2003-06-17 Council Of Scientific & Industrial Research Method of treating hyperlipidemic and hyperglycemic conditions in mammals using pregnadienols and pregnadienones
DK1392713T3 (da) * 2001-05-03 2008-02-18 Univ Chicago Lever-X-receptoragonister
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
US7078396B2 (en) 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
EP1450816A4 (en) * 2001-11-08 2008-02-13 Univ Chicago METHOD OF TREATING DISORDERS RELATED TO HIGH CHOLESTEROL RATE
AU2002356919B2 (en) * 2001-11-08 2008-04-17 The University Of Chicago Method of treating disorder related to high cholesterol concentration
US20110190323A1 (en) 2008-08-28 2011-08-04 President And Fellows Of Harvard College Cortistatin analogues and syntheses thereof
US8829213B2 (en) 2009-07-29 2014-09-09 The University Of Chicago Liver X receptor agonists
WO2013134311A1 (en) * 2012-03-07 2013-09-12 Ligand Pharmaceuticals, Inc. Steroid hormone and cholesterol pathways as one unified homestatic system
AU2014369834B2 (en) 2013-12-24 2018-12-20 President And Fellows Of Harvard College Cortistatin analogues and syntheses and uses thereof
WO2016182932A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Cortistatin analogues, syntheses, and uses thereof
EP3316889A4 (en) 2015-07-01 2018-11-14 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
US9637514B1 (en) 2015-10-26 2017-05-02 MAX BioPharma, Inc. Oxysterols and hedgehog signaling
CN111973606B (zh) * 2019-05-22 2023-05-12 王伟 一种化合物治疗血管增生以及糖尿病视网膜病变的新用途
CN116514893B (zh) * 2022-01-28 2025-12-05 珂阑(上海)医药科技有限公司 甾类化合物、其制备方法和应用
WO2023205801A2 (en) 2022-04-22 2023-10-26 Asteroid Therapeutics Steroidal compositions and methods of treating lipogenic cancers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH372297A (de) * 1959-02-10 1963-10-15 Ciba Geigy Verfahren zur Herstellung von 4-2-tert.-Aminomethyl-3-keto-steroiden
US3256302A (en) * 1960-10-20 1966-06-14 Parke Davis & Co 2-hydroxymethylene-17alpha-ethinyl-17beta-hydroxy-19-nor-4-androsten-3-one
US3314977A (en) * 1962-06-18 1967-04-18 Searle & Co Optionally 17alpha-alkylated 3-oxygenated 2alpha-dialkylaminomethyl-5alpha-androstan-17beta-ols and esters thereof
GB1015214A (en) * 1963-03-11 1965-12-31 Merck Ag E Cholesterol derivatives and preparation thereof
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
ES472877A1 (es) * 1977-08-29 1979-02-16 Searle & Co Procedimiento para preparar derivados de 25-alquilcolesterol
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
JP2550777B2 (ja) * 1990-06-29 1996-11-06 日立化成工業株式会社 ステロイドケトン系化合物，その製造法，非線形光学材料および非線形光学素子

Also Published As

Publication number Publication date
BR9301342A (pt) 1993-10-05
FI931373L (fi) 1993-09-28
EP0562849A2 (en) 1993-09-29
MX9301653A (es) 1994-02-28
EP0562849A3 (enExample) 1994-02-16
FI931373A7 (fi) 1993-09-28
JPH0656670A (ja) 1994-03-01
CN1081682A (zh) 1994-02-09
NO931117L (no) 1993-09-28
HU9300901D0 (en) 1993-06-28
NO931117D0 (no) 1993-03-25
FI931373A0 (fi) 1993-03-26
CA2092766A1 (en) 1993-09-28
IL105050A0 (en) 1993-07-08
AU3551493A (en) 1993-09-30
CZ50593A3 (en) 1993-12-15

Similar Documents

Publication Publication Date Title
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT64082A (en) Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient
HUT59106A (en) Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient
HUT52089A (en) Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT56270A (en) Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient
HUT51222A (en) Process for producing 9-halogen-/z/-prostaglandin derivatives and pharmaceutical compositions comprising such active ingredient
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
HUT60466A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient
HUT59145A (en) Process for producing substituted azole derivatives and pharmaceutical compositions such compounds as active ingredient
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT63632A (en) Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same
HUT53646A (en) Process for producing pteridin-4-(3h)-one derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT59155A (en) Process for producing corticoid-17-alkylcarbonate derivatives substituted in 17-position and pharmaceutical compositions comprising such derivatives as active ingredient
HUT49367A (en) Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
HUT62593A (en) Process for producing 3-deoxymannose amine derivatives and pharmaceutical compositions comprising such active ingredient
HUT64059A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HUT49598A (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
HUT58082A (en) Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT59116A (en) Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient
HUT63415A (en) Process for producing heterocyclic imidazole derivatives and pharmaceutical compositions comprising same as active ingredient
HUT47127A (en) Process for producing pyrimidine derivatives and pharmaceutical compositions comprising such active ingredient
HUT59917A (en) Process for producing sulfonamide derivatives and pharmaceutical compositions containing them as active component

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal